Clinical Trial Update: CEB-01 in Locally Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for CEB-01 in locally resectable pancreatic cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CEB-01

Snippet

Sponsor: CEBIOTEX | Conditions: Pancreatic Carcinoma | Phase 2 | Status: RECRUITING